Surrey Heartlands

Joint Formulary & PAD

Botulinum toxin type A - Spasmodic dysphonia

You are here : Home > Formulary Search > Botulinum toxin type A - Spasmodic dysphonia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important

RSFT - Dr Walker’s team use only; 50 units/vial. NOTE; different brands of botulinum toxin have difference licenses, please check SmPC

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Botulinum toxin type A
Indication :
Spasmodic dysphonia
Group Name :
Keywords :
Brand Names Include :
Botox, Xeomin, Dysport
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Botulinum toxin type A is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Spasmodic dysphonia.

  • No records returned.

Committee Recommendations (1)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.

See “Formulary Status” to identify where this drug has been agreed for use.